Home › Funds › TB Alternative Assets Ltd. › BNTX
TB Alternative Assets Ltd. position in BNTX
BIONTECH SE · Health Care
TB Alternative Assets Ltd. reported holding 8,700 shares of BNTX (BIONTECH SE) in its Q3 2026 13F filing — a position valued at US$855K, representing 0.18% of its reported portfolio and ranking #25 among its reported holdings. TB Alternative Assets Ltd. has disclosed BNTX holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How TB Alternative Assets Ltd.'s BNTX position evolved
TB Alternative Assets Ltd. first disclosed a stake in BNTX in Q1 2025 at 38,996 shares (US$3.6M). Across 5 filings, TB Alternative Assets Ltd. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 8,700 shares valued at US$855K. Notable position changes include a 26% trim in Q2 2025 (shares fell 7% over the following quarter), a 93% trim in Q3 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 39.00K | $3.55M | New |
| Q2 2025 | 28.92K | $3.08M | Reduce |
| Q3 2025 | 2.10K | $207.50K | Reduce |
| Q4 2025 | 2.10K | $200.30K | Hold |
| Q3 2026 | 8.70K | $855.21K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 35 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- FLOSSBACH VON STORCH SE 2.23M sh · $207.14M · Q2 2026
- Temasek Holdings (Private) Ltd 1.51M sh · $140.14M · Q2 2026
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- GSK plc 889.82K sh · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K sh · $70.21M · Q2 2026
- Long Focus Capital Management, LLC 624.00K sh · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on TB Alternative Assets Ltd.
FAQ
How long has TB Alternative Assets Ltd. held BNTX?
TB Alternative Assets Ltd. has disclosed BNTX holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
What is TB Alternative Assets Ltd.'s current position in BNTX?
As of Q3 2026, TB Alternative Assets Ltd. holds 8.70K shares of BNTX (BIONTECH SE), valued at $855.21K, representing 0.18% of its reported portfolio and ranking #25.
Has TB Alternative Assets Ltd. been buying or selling BNTX?
In the latest 13F filing (Q3 2026), TB Alternative Assets Ltd. newly opened its position in BNTX.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.